Author

H Demuynck

Observed names: DEMUYNCK H, Demuynck, H, Demuynck, Hilde, H. DeMuynck, H. Demuynck, H.M. Demuynck, H.M.S Demuynck, Hilda Demuynck, Hilde Demuynck

Observed institutions: Radboud University Nijmegen, University of Ferrara, Universitair Ziekenhuis Leuven, Ghent University Hospital, Radboud University Medical Center, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust, Belgian Hematological Society, Algemeen Ziekenhuis Sint-Maria Halle, University of Göttingen, KU Leuven

OpenAlex ID: A5111673971

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1996 · N Schmitz, P Dreger, et al. · The Lancet · 610

Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis

1999 · J Maertens, H Demuynck, et al. · Bone Marrow Transplantation · 213

Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels

1989 · M.A. Boogaerts, G.E. Verhoef, et al. · Mycoses · 189

Cytogenetic profile of minimally differentiated (FAB M0) acute myeloid leukemia: correlation with clinicobiologic findings [see comments]

1995 · A Cuneo, A Ferrant, et al. · Blood · 102

PDF

Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features.

1997 · A Cuneo, A Ferrant, et al. · PubMed · 83

Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes

1995 · M Delforge, H Demuynck, et al. · Blood · 79

PDF

Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40

2011 · A W Rijneveld, B van der Holt, et al. · Leukemia · 78

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

2025 · Michael Wang, Michael Wang, et al. · Journal of Clinical Oncology · 67

Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma

2004 · I Wlodarska, P Meeus, et al. · Leukemia · 56

Risks of rhG-CSF treatment in drug-induced agranulocytosis

1995 · H. Demuynck, P. Zachée, et al. · Annals of Hematology · 50

The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow

1992 · N.G. Testa, H. Demuynck, et al. · European Journal of Cancer · 50

Recombinant human erythropoietin for the treatment of anemia in the myelodysplastic syndromes: A clinical and erythrokinetic assessment

1992 · G. E. G. Verhoef, P. Zachée, et al. · Annals of Hematology · 50

Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.

1996 · H Demuynck, G E Verhoef, et al. · PubMed · 48

Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor‐risk myelodysplastic syndromes

1996 · H. Demuynck, M. Delforge, et al. · British Journal of Haematology · 48

PDF

Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib

2003 · P Meeus, H Demuynck, et al. · Leukemia · 47

The engraftment capacity of peripheral blood progenitor cells (PBPC) mobilised with chemotherapy ± G-CSF

1992 · R Pettengell, H Demuynck, et al. · Stem Cells · 34

Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL

2004 · L Michaux, I Wlodarska, et al. · Leukemia · 31

Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?

2004 · L. Ide, I. Buysschaert, et al. · Clinical Microbiology and Infection · 24

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON

2012 · S Daenen, B van der Holt, et al. · Leukemia · 23

Quantitative determination of immunological components of salivary gland secretion in transplant recipients.

1996 · F Dens, M Boogaerts, et al. · PubMed · 23

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

2017 · N J Bahlis, A Corso, et al. · Leukemia · 20

PDF

Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?

1994 · G E Verhoef, H Demuynck, et al. · PubMed · 20

High-dose melphalan allows durable engraftment of allogeneic bone marrow.

1995 · K van Besien, H Demuynck, et al. · PubMed · 17

Hypercalcemia, monoclonal protein, and osteolytic bone lesions in chronic lymphocytic leukemia

1994 · M. Van de Casteele, G. E. G. Verhoef, et al. · Annals of Hematology · 17

Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome

1996 · P. Vandenberghe, P. Zachee, et al. · Annals of Hematology · 14

Works count: 71

Citation count: 2,100

H-index: 20

I10-index: 29